Home
  >  
Section 9
  >  
Chapter 8,466

Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs

Vanderford, P.A.; Wong, J.; Chang, R.; Keefer, L.K.; Soifer, S.J.; Fineman, J.R.

Journal of Cardiovascular Pharmacology 23(1): 113-119

1994

ISSN/ISBN: 0160-2446
PMID: 7511722
DOI: 10.1097/00005344-199401000-00016
Accession: 008465464
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Nitric oxide (NO), a labile humoral factor produced by vascular endothelial cells, is a potent vasodilator and an important mediator of pulmonary vascular tone. Nucleophile/NO adducts are a new class of compounds that spontaneously and predictively release NO. We investigated the hemodynamic effects of intravenous (i.v.) infusions of a recently developed NO-donor drug, the diethylamine-nitric oxide adduct (DEA/NO), in 17 intact newborn lambs. At rest, DEA/NO (1-2 mu-g cntdot kg-1 cntdot min-1) produced dose-dependent decreases in mean pulmonary (from 10.6 +- 8.6 to 21.2 +- 7.9%, p lt 0.05) and systemic arterial pressure (from 13.2 +- 11.7 to 31.0 +- 15.4%, p lt 0.05).

Full Text Article emailed within 0-6 h: $19.90




Related References

Vanderford, P.A.; Wong, J.; Winters, J.W.; Chang, R.; Soifer, S.J.; Fineman, J.R. 1993: DEA/NO, a nitric oxide donor, produces potent pulmonary and systemic vasodilation in the intact newborn lamb Clinical Research 41(2): 297A
Vanderford, P.A.; Wong, J.; Winters, J.W.; Chang, R.; Soifer, S.J.; Fineman, J.R. 1993: DEA-nitric oxide, a nitric oxide donor, produces potent pulmonary and systemic vasodilation in the intact newborn lamb Pediatric Research 33(4 Part 2): 70A
Cornfield, D.N.; Martin, E.B.; Hampl, V.; Archer, S.L. 1999: Aerosol delivery of diethylenetriamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs Journal of Laboratory and Clinical Medicine 134(4): 419-425
Fineman, J.R.; Wong, J.; Soifer, S.J. 1993: Hyperoxia and alkalosis produce pulmonary vasodilation independent of endothelium-derived nitric oxide in newborn lambs Pediatric Research 33(4 Part 1): 341-346
Fineman, J.R.; Wong, J.; Soifer, S.J. 1993: Hyperoxia and Alkalosis Produce Pulmonary Vasodilation Independent of Endothelium-Derived Nitric Oxide in Newborn Lambs Pediatric Research 33(4): 341-346
Fineman, J.R.; Wong, J.; Morin, F.C.; Wild, L.M.; Soifer, S.J. 1994: Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs Journal of Clinical Investigation 93(6): 2675-2683
Fineman, J.R.; Soifer, S.J. 1992: Hyperoxia and alkalosis produce pulmonary vasodilation independent of endothelium derived nitric oxide synthesis in newborn lambs Pediatric Research 31(4 Part 2): 307A
Wong, J.; Vanderford, P.A.; Fineman, J.R.; Chang, R.; Soifer, S.J. 1993: Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb American Journal of Physiology 265(4 Part 2): H1318-H1325
Wong, J.; Vanderford, P.A.; Winters, J.; Soifer, S.J.; Fineman, J.R. 1995: Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension Journal of Cardiovascular Pharmacology 25(2): 207-215
Fineman, J.R.; Soifer, S.J. 1991: L arginine a precursor of edrf synthesis produces pulmonary vasodilation in the intact newborn lamb Pediatric Research 29(4 Part 2): 317A
Wong, J.; Winters, J.W.; Vanderford, P.A.; Fineman, J.R.; Soifer, S.J. 1993: ET-b-receptor agonists produce potent pulmonary vasodilation in the intact newborn lamb Pediatric Research 33(4 Part 2): 71A
Levy, R.D.; Mehta, S.; Langleben, D.; Stewart, D.J. 1993: L-arginine produces pulmonary vasodilation in pulmonary hypertension via enhanced endogenous nitric oxide production Clinical and Investigative Medicine 16(4 Suppl): B124
Mehta, S.; Stewart, D.J.; Hussain, S.; Levy, R.D. 1994: L-arginine produces systemic vasodilation and increased nitric oxide excretion in expired gas in humans Clinical and Investigative Medicine 17(4 Suppl): B123
Mehta, S.; Stewart, D.J.; Hussain, S.; Levy, R.D. 1994: L-Arginine produces systemic vasodilation and increase nitric oxide excretion in expired gas in humans Circulation 90(4 Part 2): I138
Curtis, J.; Palacino, J.J.; O'neill, J.T.mothy 1994: Tolazoline produces pulmonary vasodilation independent of nitric oxide production Pediatric Research 37(4 Part 2): 201A
Martin, E.B.; Tolarova, S.; Weir, E.K.; Archer, S.L.; Cornfield, D.N. 1996: Aerosol delivery of DeTANO, a nitric oxide adduct, causes selective and sustained perinatal pulmonary vasodilation Pediatric Research 39(4 Part 2): 339A
Konduri, G.G.; Mital, S. 2000: Adenosine and Atp Cause Nitric Oxide-Dependent Pulmonary Vasodilation in Fetal Lambs Neonatology 78(3): 220-229
Ganesh Konduria, G.; Mital, S. 2000: Adenosine and ATP cause nitric oxide-dependent pulmonary vasodilation in fetal lambs Biol. Neonate 78(3): 220-229
Konduri, G.G.; Mital, S. 2000: Adenosine and ATP cause nitric oxide-dependent pulmonary vasodilation in fetal lambs Biology of the Neonate 78(3): 220-229
Adrie, C.; Hirani, W.M.; Holzmann, A.; Keefer, L.; Zapol, W.M.; Hurford, W.E. 1998: Selective pulmonary vasodilation by intravenous infusion of an ultrashort half-life nucleophile/nitric oxide adduct Anesthesiology 88(1): 190-195